Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 10Lung Neoplasms 4Non Small Cell Lung Cancer Metastatic 3Neoplasms 2Recurrence 1Neoplasm Metastasis 1Neoadjuvant Non-Small Cell Lung Cancer 1Lymphoma, Large-Cell, Anaplastic 1Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer 1Advanced Non-Small Cell Lung Cancer 1ALK Positive Non-small Cell Lung Cancer 1

Interventions

lorlatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer × lorlatinib × Clear all
NCT05297890 2026-05-19

A Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung Cancer

CStone Pharmaceuticals

Phase 2 Active not recruiting
70 enrolled
Thoracic

Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡